GLP-1RA Exposure and Nonarteritic Anterior Ischemic Optic Neuropathy Prevalence by Diabetes Status
Pallavi Nagdeve, Russell Griffin
Abstract
This case-control study examines glucagon-like peptide-1 receptor agonist (GLP-1RA) exposure and prevalence of nonarteritic anterior ischemic optic neuropathy (NAION) among patients with type 2 diabetes, obesity, or neither diagnosis.
Topics & Concepts
Anterior ischemic optic neuropathyMedicineDiabetes mellitusOptic neuropathyOphthalmologyObesityType 2 diabetesInternal medicineAgonistGlucagon-like peptide-1Optic nerveEndocrinologyReceptorIntraoperative Neuromonitoring and Anesthetic EffectsAnesthesia and Pain ManagementIntracranial Aneurysms: Treatment and Complications